BioCentury | Aug 23, 2018
Distillery Therapeutics

Neurology

...July 23, 2018 doi:10.1523/JNEUROSCI.0478-18.2018 CONTACT: Praveen Ballabh, Albert Einstein College of Medicine, Bronx, N.Y. email: Pballabh@msn.com Claire...
BioCentury | Apr 4, 2017
Distillery Therapeutics

Cancer

...INDICATION: Melanoma Mouse studies suggest combining MSN inhibition with adoptive T cell therapy could help treat...
...of melanoma receiving mouse CD8 + T cells expressing a melanoma antigen, systemic knockout of MSN...
...could include identifying and testing MSN inhibitors in combination with adoptive T cell therapy. TARGET/MARKER/PATHWAY: Moesin (MSN)...
BioCentury | Dec 12, 2013
Distillery Therapeutics

Indication: Neurology

...doi:10.1523/JNEUROSCI.2713-13.2013 Contact: Praveen Ballabh, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, N.Y. e-mail: pballabh@msn.com BC...
BioCentury | Jan 31, 2013
Distillery Therapeutics

Indication: Neurology

...published online Jan. 9, 2013; doi:10.1523/JNEUROSCI.4445-12.2013 Contact: Praveen Ballabh, Westchester Medical Center, Valhalla, N.Y. e-mail: pballabh@msn.com BC...
BioCentury | Apr 19, 2012
Distillery Therapeutics

Indication: Neurology

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Autism Moesin pseudogene 1 antisense (MSNP1AS...
...help treat autism. Previous genomewide association studies had identified a chromosomal region containing the noncoding moesin...
...were higher than those in healthy controls. In cell culture, MSNP1AS overexpression decreased levels of moesin...
BioCentury | Sep 1, 2011
Distillery Therapeutics

Indication: Neurology

...Praveen Ballabh, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, N.Y. phone: 914-953-1936 e-mail: pballabh@msn.com...
...doi:10.1523/JNEUROSCI.0013-11.2011 Contact: Praveen Ballabh, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, N.Y. e-mail: pballabh@msn.com BC...
Items per page:
1 - 6 of 6